Imarat has an established presence in the UAE through its subsidiary – Graana.com
The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official said, more than three months after Britain's green light on Wednesday.
Moncef Slaoui, the chief advisor to Operation Warp Speed, the military-led US effort for vaccines, told reporters that US trials and assessments would be complete for approval "sometime in early April."
Also read: Covid-19: US's race to vaccinate millions off to slow, messy start
"Several tens of millions of doses will have been manufactured... and therefore will be available for use if the data supports its approval," he said.
He did not allege that Britain rushed its decision and praised Britain's MHRA regulatory agency as "science-based."
"Therefore I am not raising any question as to the decision that they have made," he said.
"Having said that, the requirements of the decision process as we have built it here in the US is what I can really comment on."
Slaoui also voiced hope for approval in the first half of February of the Janssen vaccine by Johnson & Johnson, which in contrast to the initially approved vaccines comes in a single dose.
Imarat has an established presence in the UAE through its subsidiary – Graana.com
Mikhail Mishustin promises to do everything to develop the economy
The Neurogeocoder API is a powerful tool for various industries, including e-commerce, real estate, food-tech, ride-tech, and logistics
As Israel closed the border to achieve the goal of destroying Hamas, truck drivers fear the food could spoil
Some of the treaty's most contentious elements includes vaccine sharing
The Man City manager praises the club's medical department and reveals that there are no worries on the injury front ahead of Saturday's Fulham encounter
Antonio Guterres warns that the situation in the southern Gaza city is "on a knife's edge"
Ministry of Interior data also showed Abu Dhabi topped the list of fatalities, while Dubai topped the most number of injuries in 2023